Age-specific 1-year Mortality Rates After Hip Fracture Based on the Populations in Mainland China Between the Years 2000 and 2018: a Systematic Analysis
Overview
Authors
Affiliations
Introduction: Data on the 1-year mortality rates after hip fracture in mainland China remain limited and localized. We aimed to analyze the 1-year mortality rates and reveal the variations in 1-year mortality by age after hip fracture based on data from mainland China.
Methods: We searched PubMed, EMBASE, Cochrane Library, CNKI, Wanfang, and CBM-SinoMed for all relevant articles in English or Chinese to estimate the 1-year mortality rates after hip fracture in mainland China. A random-effects meta-analysis model was fitted to pool the overall 1-year mortality rates. A multilevel mixed-effects meta-regression model was developed. Based on the final model, the age-specific 1-year mortality rates after hip fracture in mainland China were generated.
Results: The pooled estimate of the 1-year mortality rate was 13.96% after hip fracture (95% CI 12.26 to 15.86%), 17.47% after femoral intertrochanteric fracture (95% CI 14.29 to 21.20%), and 9.83% after femoral neck fracture (95% CI 6.96 to 13.72%) between the years 2000 and 2018. We found that the 1-year mortality rates ranged from 2.65% (95% CI 1.76 to 3.99%) in those aged 50~54 years to 28.91% (95% CI 24.23 to 34.30%) in those aged 95~99 years after hip fracture; ranged from 1.73% (95% CI 0.58 to 4.99%) in those aged 50~54 years to 50.11% (95% CI 46.03% to 53.97%) in those aged 95~99 years after femoral intertrochanteric fracture; and ranged from 1.66% (95% CI 1.31 to 2.11%) in those aged 60~64 years to 37.71% (95% CI 27.92 to 48.63%) in those aged 95~99 years after femoral neck fracture.
Conclusion: In this systematic review and meta-analysis, we calculated the 1-year mortality rate after hip fracture in mainland China and found that this rate was lower than that in most countries. We also estimated the age-specific mortality rates for different age groups after hip fracture. These findings will be beneficial for the prevention and treatment of hip fracture in mainland China.
Li E, Hu J, Chen Z, Ma R, Jin C, Bu Y BMC Musculoskelet Disord. 2025; 26(1):21.
PMID: 39762857 PMC: 11702231. DOI: 10.1186/s12891-024-08183-6.
Lou L, Xu L, Wang X, Xia C, Dai J, Hu L Eur J Med Res. 2024; 29(1):626.
PMID: 39726041 PMC: 11670504. DOI: 10.1186/s40001-024-02244-1.
Han X, Han L, Chu F, Liu B, Song F, Jia D J Orthop Surg Res. 2024; 19(1):701.
PMID: 39472932 PMC: 11523668. DOI: 10.1186/s13018-024-05219-4.
Wang P, Guo S BMC Musculoskelet Disord. 2024; 25(1):678.
PMID: 39210355 PMC: 11360289. DOI: 10.1186/s12891-024-07814-2.
Causal associations of interleukins and osteoporosis: A genetic correlation study.
Chen H, Lin H, Dai J Medicine (Baltimore). 2024; 103(32):e39036.
PMID: 39121248 PMC: 11315551. DOI: 10.1097/MD.0000000000039036.